Ken Takase

1.3k total citations
49 papers, 774 citations indexed

About

Ken Takase is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Ken Takase has authored 49 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 24 papers in Oncology and 13 papers in Immunology. Recurrent topics in Ken Takase's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (12 papers) and Immune Cell Function and Interaction (6 papers). Ken Takase is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (12 papers) and Immune Cell Function and Interaction (6 papers). Ken Takase collaborates with scholars based in Japan, Norway and United States. Ken Takase's co-authors include Toshihiro Miyamoto, Akihiko Numata, Koji Nagafuji, Hisashi Gondo, Kenichi Aoki, Kazuya Shimoda, Kouji Kato, Mine Harada, Tadashi Matsuda and Hideho Henzan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Ken Takase

46 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Takase Japan	14	339	337	237	146	110	49	774
Leopold Oehler Austria	13	173 0.5×	357 1.1×	192 0.8×	154 1.1×	115 1.0×	21	762
Costas Tsatalas Greece	13	131 0.4×	306 0.9×	366 1.5×	103 0.7×	181 1.6×	37	739
Angela Hamblin United Kingdom	11	179 0.5×	157 0.5×	207 0.9×	288 2.0×	202 1.8×	32	708
Tomoko Ohtsu Japan	16	374 1.1×	198 0.6×	126 0.5×	176 1.2×	88 0.8×	33	758
Patrizia Lista Italy	12	173 0.5×	252 0.7×	325 1.4×	181 1.2×	67 0.6×	34	735
AR Zander Germany	10	230 0.7×	177 0.5×	275 1.2×	107 0.7×	81 0.7×	21	633
Yasunori Nakagawa Japan	13	255 0.8×	250 0.7×	232 1.0×	278 1.9×	77 0.7×	37	688
Federico Chiurazzi Italy	16	136 0.4×	242 0.7×	164 0.7×	162 1.1×	271 2.5×	32	692
Antònia Sampol Spain	14	189 0.6×	161 0.5×	430 1.8×	117 0.8×	153 1.4×	60	731
Toshiki Yamada Japan	18	336 1.0×	274 0.8×	441 1.9×	135 0.9×	249 2.3×	61	1.1k

Countries citing papers authored by Ken Takase

Since Specialization

Citations

This map shows the geographic impact of Ken Takase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takase more than expected).

Fields of papers citing papers by Ken Takase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Takase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takase. The network helps show where Ken Takase may publish in the future.

Co-authorship network of co-authors of Ken Takase

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takase. A scholar is included among the top collaborators of Ken Takase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takase. Ken Takase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamae, Hirohisa, Eisei Kondo, Takahiro Fukuda, et al.. (2024). Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone Marrow Transplantation. 59(5). 630–636. 1 indexed citations

Wang, Ziyao, Hiromi Iwasaki, Ken Takase, et al.. (2021). Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults. Diagnostic Pathology. 16(1). 48–48. 3 indexed citations

Henzan, Hideho, Ken Takase, Tomohiko Kamimura, et al.. (2020). Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. International Journal of Hematology. 112(3). 349–360.

Nagafuji, Koji, Toshihiro Miyamoto, Tetsuya Eto, et al.. (2019). Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia. European Journal Of Haematology. 103(3). 164–171. 8 indexed citations

Yamasaki, Satoshi, et al.. (2019). Acquired Hemophilia A Associated with Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan. Diabetes Therapy. 10(3). 1139–1143. 4 indexed citations

Yamasaki, Satoshi, Kazuki Tanimoto, Masanori Kadowaki, et al.. (2014). UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan. Annals of Hematology. 94(1). 65–69. 7 indexed citations

Takashima, Shuichiro, Toshihiro Miyamoto, Masanori Kadowaki, et al.. (2014). Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients. International Journal of Hematology. 100(2). 159–164. 6 indexed citations

Eto, Tetsuya, Ken Takase, Toshihiro Miyamoto, et al.. (2013). Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. International Journal of Hematology. 98(2). 186–196. 7 indexed citations

Ito, Yoshikiyo, Toshihiro Miyamoto, Tomohiko Kamimura, et al.. (2013). Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group. International Journal of Hematology. 98(4). 463–471. 4 indexed citations

10.

Takenaka, Katsuto, Koji Nagafuji, Ken Takase, et al.. (2012). Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. International Journal of Hematology. 96(1). 94–100. 7 indexed citations

11.

Kohno, Keizo, Koji Nagafuji, Hiroshi Tsukamoto, et al.. (2009). Infectious complications in patients receiving autologous CD34‐selected hematopoietic stem cell transplantation for severe autoimmune diseases. Transplant Infectious Disease. 11(4). 318–323. 22 indexed citations

12.

Kamezaki, Kenjiro, Yoshikane Kikushige, Akihiko Numata, et al.. (2007). Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma. Bone Marrow Transplantation. 39(9). 523–527. 18 indexed citations

13.

Kikushige, Yoshikane, Ken Takase, Toshihiro Miyamoto, et al.. (2006). Late Relapse of Acute Myelogenous Leukemia Followed by Epstein-Barr Virus-Associated Lymphoproliferative Disease 11 Years after Allogeneic Bone Marrow Transplantation. International Journal of Hematology. 84(5). 441–444. 2 indexed citations

14.

Miyamoto, Toshihiro, Goichi Yoshimoto, Kenjiro Kamezaki, et al.. (2005). Mobilization of Human Lymphoid Progenitors after Treatment with Granulocyte Colony-Stimulating Factor. The Journal of Immunology. 175(4). 2647–2654. 24 indexed citations

15.

Henzan, Hideho, Goichi Yoshimoto, Yoji Nagasaki, et al.. (2004). Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia. Annals of Hematology. 83(12). 784–788. 6 indexed citations

16.

Aoki, Kenichi, Kazuya Shimoda, Kenji Oritani, et al.. (2003). Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. Experimental Hematology. 31(12). 1317–1322. 12 indexed citations

17.

Shimoda, Kazuya, Akihiko Numata, Kenichi Aoki, et al.. (2003). The lipocalin 24p3, which is an essential molecule in IL‐3 withdrawal‐induced apoptosis, is not involved in the G‐CSF withdrawal‐induced apoptosis. European Journal Of Haematology. 71(6). 412–417. 12 indexed citations

18.

Shimoda, Kazuya, Akihiko Numata, Kenichi Aoki, et al.. (2002). Cutting Edge: Tyk2 Is Required for the Induction and Nuclear Translocation of Daxx Which Regulates IFN-α-Induced Suppression of B Lymphocyte Formation. The Journal of Immunology. 169(9). 4707–4711. 52 indexed citations

19.

Numata, Akihiko, Kazuya Shimoda, Hisashi Gondo, et al.. (2002). Therapy‐related chronic myelogenous leukaemia following autologous stem cell transplantation for Ewing's sarcoma. British Journal of Haematology. 117(3). 613–616. 7 indexed citations

20.

Shimoda, Kazuya, Kouji Kato, Kenichi Aoki, et al.. (2000). Tyk2 Plays a Restricted Role in IFNα Signaling, Although It Is Required for IL-12-Mediated T Cell Function. Immunity. 13(4). 561–571. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact